Skip to main content
. Author manuscript; available in PMC: 2009 Jun 1.
Published in final edited form as: Neurobiol Aging. 2007 Feb 8;29(6):836–847. doi: 10.1016/j.neurobiolaging.2006.12.018

Table 1.

Summary of the Sets of Scans from AD-Transgenic- and Wild-type Mice Imaged In Vivo with μMRI*

Mice Set 1
(2 scans compared without contrast agent)
Set 2
(Gd-K6Aβ1–30 injection scan compared to pre-ligand injection scan)
Set 3
(Magnevist control injection scan compared to pre-ligand injection scan)
Transgenic 11 APP/PS1 Tg (In the first scan no injection was given. In the second scan 8 mice received no injection and 3 mice received DTPA-K6Aβ1–30 with no Gd.) 9 (3 APP/PS1 Tg and 6 APP Tg)
Wild-type 10 5 5
*

Quantitative analysis of these sets is presented in Figure 5, in which the wild-type scans were combined.